Kenneth A. Berlin has been appointed president and chief executive officer, Rosetta Genomics, Ltd., and has been recommended to serve on the company’s board of directors. Mr. Berlinpreviously served as worldwide general manager at Veridex, LLC, a Johnson & Johnson company. Under his leadership the organization grew to more than 100 employees, and he spearheaded the launch of three cancer diagnostic products. Mr. Berlin joined J&J in 1994 and served as corporate counsel for six years....